Astec Lifesciences board to consider fund raising proposal

Astec Lifesciences (BSE:ASTEC) has announced that a meeting of its Board of Directors is scheduled for June 24, 2025, to consider a proposal for raising funds through equity shares or other securities. The fund raising method is subject to regulatory and statutory approvals. In compliance with insider trading regulations, the trading window for the company's securities will be closed from the time of the announcement until 48 hours after the Board Meeting outcome's publication. The company has made the announcement available on its website, and requested that the announcement should be put on record.